• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Header cover image

U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

10 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
REGNRegeneron PharmaceuticalsUS$640.890.2%15.3%US$67.8bUS$677.45P/E10.7xE-4.5%n/a
BIOBio-Rad LaboratoriesUS$782.52-1.2%51.1%US$23.5bUS$771.25P/E5.8xE-41.1%n/a
STVNStevanato GroupUS$26.892.4%n/aUS$7.2bUS$27.02P/E50xE3.2%0%
SAGESage TherapeuticsUS$45.22-0.2%-24.5%US$2.7bUS$83.00P/E4xE24.0%n/a
ORGOOrganogenesis HoldingsUS$15.752.4%309.1%US$2.1bUS$26.75P/E28.9xE17.9%n/a
QUREuniQureUS$36.623.9%-5.4%US$1.7bUS$66.29P/E5.6xE-50.8%n/a
ATRSAntares PharmaUS$3.670%32.0%US$635.7mUS$6.64P/E9.7xE28.4%n/a
CPRXCatalyst PharmaceuticalsUS$4.85-2.8%51.1%US$520.0mUS$8.30P/E6.7xE8.4%n/a
SIGASIGA TechnologiesUS$6.590.8%-8.3%US$508.3mn/aP/E11.3xE18.0%n/a
ELTPElite PharmaceuticalsUS$0.045-2.3%-37.4%US$47.5mn/aP/E7.1xn/an/a
Page 1 of 1